MedTrace Logo

Assessment of Efficacy of Neoadjuvant Therapy in Locally Advanced Rectal Cancer

NCT06314737 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3515

Last updated 2024-03-18

No results posted yet for this study

Summary

This study analyzed the efficacy differences between neoadjuvant therapy and direct surgical treatment in patients with locally advanced rectal cancer in the real world. The aim was to evaluate the impact of neoadjuvant therapy on overall survival, disease-free survival, and local recurrence-free survival in patients with locally advanced rectal cancer, explore the population benefiting most from neoadjuvant therapy, and provide evidence-based medicine for the benefits of neoadjuvant therapy in patients with colorectal cancer in the real world.

Conditions

  • Locally Advanced Rectal Carcinoma

Sponsors & Collaborators

  • Sixth Affiliated Hospital, Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Zerong Cai, MD · Sixth Affiliated Hospital, Sun Yat-sen University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-02
Primary Completion
2018-12-06
Completion
2024-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06314737 on ClinicalTrials.gov